Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT04116437
Diagnosis Type: Lymphomas
USOR Number: 18263

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1/2 Study of VS-6766 in Combination with Sotorasib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203) (VS-6766-203)

  • Details

ClinicalTrials.gov ID: NCT05074810
Diagnosis Type: Lung Cancer
USOR Number: 21498

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1, First-In-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second LIne and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (CUE-101-01)

  • Details

ClinicalTrials.gov ID: NCT03978689
Diagnosis Type: Head and Neck Cancer
USOR Number: 21459

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression (IMGN853-0419)

  • Details

ClinicalTrials.gov ID: NCT05041257
Diagnosis Type: Peritoneal Cancer
USOR Number: 21369

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

AN OPEN-LABEL, MULTICENTER, PHASE II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SUBCUTANEOUS MOSUNETUZUMAB MONOTHERAPY IN PATIENTS WITH SELECT B-CELL MALIGNANCIES (ML43389)

  • Details

ClinicalTrials.gov ID: NCT05207670
Diagnosis Type: Lymphomas
USOR Number: 21356

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Solid Tumors

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

VNC-152-101: An Open-Label, Multicenter Phase I Dose Escalation Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity, Pharmacokinetics and Maximum Tolerated Dose of VIP152 (BAY 1251152) as monotherapy or in combination with KEYTRUDA® (pembrolizumab) in Subjects with Advanced Cancer

  • Details

ClinicalTrials.gov ID: NCT02635672
Diagnosis Type: Solid Tumors
USOR Number: 21346

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

UPIFITAMAB RILSODOTIN (XMT-1536)AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND EXPANSION STUDY OF UPIFITAMAB RILSODOTIN IN COMBINATION WITH CARBOPLATIN IN PARTICIPANTS WITH HIGH-GRADE SEROUS OVARIAN CANCER: A MODULAR STUDY RELATED TO UPGRADE UMBRELLA MASTER STUDY (UPGRADE-A) (MER-XMT-1536-2A)

  • Details

ClinicalTrials.gov ID: NCT04907968
Diagnosis Type: Peritoneal Cancer
USOR Number: 21309

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1/2 Dose-Escalation and Dose-Expansion Study of ZN‑c3 in Combination with Niraparib in Subjects with Platinum-Resistant Ovarian Cancer (ZN-c3-006)

  • Details

ClinicalTrials.gov ID: NCT05198804
Diagnosis Type: Ovarian Cancer
USOR Number: 21308

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

  • Details

ClinicalTrials.gov ID: NCT03872947
Diagnosis Type: Peritoneal Cancer
USOR Number: 21304

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma(FLORA-5)(QPT-ORE-005/GOG-3035)

  • Details

ClinicalTrials.gov ID: NCT04498117
Diagnosis Type: Peritoneal Cancer
USOR Number: 21253

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page
1 2 3 6